Evidence map›Paper›PMID 34388690›Full record

ArticleESMO open2021

Management of lung cancer patients' quality of life in clinical practice: a Delphi study.

V Westeel, M Bourdon, A B Cortot, D Debieuvre, A-C Toffart, M Acquadro, B Arnould, J Lambert, F-E Cotte, A-F Gaudin and 1 more

Abstract read
In one paragraph

Article in ESMO open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

V WesteelUnité de Méthodologie et de Qualité de Vie en Cancérologie, Centre Hospitalier Universitaire de Besançon, UMR1098, Université de Franche-Comté, Besançon, France.
M BourdonInstitut de Cancérologie de l'Ouest, Nantes, Angers, France; UMR INSERM 1246 SPHERE, Université de Nantes, Université de Tours, Tours, France.
A B CortotUniversity of Lille, Centre Hospitalier Universitaire de Lille, CNRS, Inserm, Institut Pasteur de Lille, UMR9020-UMR-S 1277-Canther, Lille, France.
D DebieuvreGHRMSA-Hôpital Emile Muller, Mulhouse, France.
A-C ToffartCentre Hospitalier Universitaire de Grenoble Alpes, Grenoble, France.
M AcquadroPatient Centred Outcomes, ICON plc, Lyon, France.
B ArnouldPatient Centred Outcomes, ICON plc, Lyon, France.
J LambertPatient Centred Outcomes, ICON plc, Lyon, France. Electronic address: jeremy.lambert@iconplc.com.
F-E CotteBristol-Myers Squibb, Rueil-Malmaison, France.
A-F GaudinBristol-Myers Squibb, Rueil-Malmaison, France.
H LemassonBristol-Myers Squibb, Rueil-Malmaison, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe assessment of health-related quality of life (HRQoL) has seen exponential growth in oncology clinical trials. However, the measurement of HRQoL has yet to be optimised in routine clinical practice. This study aimed at exploring the operationalisation of HRQoL in clinical practice with the goal of reaching a consensus from a panel of physicians. MATERIALS AND

methodsPhysicians involved in the management of lung cancer patients in France were recruited to participate in a Delphi study. The study involved three rounds of iterated queries to gain consensus on management aspects of HRQoL, including timing of discussion on HRQoL, which specific domains of HRQoL should be discussed, and what was the most appropriate method of assessment. The threshold adopted for consensus was at least 70% agreement among physicians. A scientific committee reviewed results following each round of the Delphi study.

resultsA representative panel of 60 physicians participated in this study. Consensus was obtained for HRQoL management at all time points in the patient care pathway. Panellists agreed that HRQoL discussions should occur during routine visits and hospitalisation. The involvement of patients' relatives was also recognised as important, except when discussing side-effects and involvement of a multidisciplinary team. There was a lack of consensus on a systematic assessment for all patients at each visit and no consensus on how HRQoL should be measured in clinical practice.

conclusionsHRQoL discussions are considered an integral part in the management of lung cancer patients, and are deemed key to success in patient-physician interaction. Further research is required to harmonise how best to implement HRQoL assessment.

Indexed as

Lung NeoplasmsPhysiciansConsensusDelphi TechniqueHumansQuality of Lifeclinical practiceDelphi studylung cancerquality of life

Identifiers

PMID34388690
PMCPMC8363823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.